New implantable glucose monitor goes Head-to-Head with current tech
NCT ID NCT07386340
Summary
This study is testing a new, long-term glucose monitoring system called Eversense Gemini. It aims to see if this new device is as accurate and safe as the current Eversense 365 system for people with diabetes. About 80 adults with type 1 or type 2 diabetes will wear both monitors to compare how well they track blood sugar levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Headlands Research - AMCR Institute
RECRUITINGEscondido, California, 92025, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.